MAIA CEO Vlad Vitoc Buys 73,000 Shares

What Happened
Vlad Vitoc, CEO of MAIA Biotechnology, reported a purchase of 73,000 shares on 2026-09-14 at $1.37 per share, for a total reported value of $100,010. The transaction is coded as a purchase (P) — an acquisition rather than a sale.

Key Details

• Transaction date and price: Sep 14, 2026 — 73,000 shares at $1.37 each.
• Total reported value: $100,010.
• Transaction type: Purchase (code P) — open market or private purchase as reported.
• Shares owned after transaction: Not specified in this Form 4.
• Footnote: F1 states these securities are beneficially owned by Mr. Vitoc’s spouse; Mr. Vitoc disclaims beneficial ownership except to the extent of any pecuniary interest.
• Filing timeliness: Form 4 filed on Sep 15, 2026 (one day after the transaction), which is timely under standard reporting rules.

Context
Purchases by executives are often watched by investors as a potential positive signal, but the footnote indicates these shares are held in the CEO’s spouse’s name, which may affect how directly this reflects the CEO’s personal holdings. This report is a straightforward purchase disclosure, not an option exercise, gift, or tax-withholding event.